Literature DB >> 34537188

Pulmonary Hypertension: A New Vascular Complication of Diabetes?

Julia W Gallini1, David Benkeser2, Xiangqin Cui3, Amit J Shah4, Lawrence S Phillips5, Anna R Hemnes6, C Michael Hart7, Aaron W Trammell8.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34537188      PMCID： PMC8941604          DOI： 10.1016/j.chest.2021.09.005

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   10.262


× No keyword cloud information.
  9 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Insulin resistance in pulmonary arterial hypertension.

Authors:  R T Zamanian; G Hansmann; S Snook; D Lilienfeld; K M Rappaport; G M Reaven; M Rabinovitch; R L Doyle
Journal:  Eur Respir J       Date:  2008-12-01       Impact factor: 16.671

3.  Diabetes Complications Severity Index (DCSI)-Update and ICD-10 translation.

Authors:  William P Glasheen; Andrew Renda; Yanting Dong
Journal:  J Diabetes Complications       Date:  2017-03-14       Impact factor: 2.852

4.  Mortality in US veterans with pulmonary hypertension: a retrospective analysis of survival by subtype and baseline factors.

Authors:  Aaron W Trammell; Amit J Shah; Lawrence S Phillips; C Michael Hart
Journal:  Pulm Circ       Date:  2019 Jan-Mar       Impact factor: 3.017

5.  Validity of the primary care diagnosis of diabetes in veterans in the southeastern United States.

Authors:  Jennifer G Twombly; Qi Long; Ming Zhu; Lisa-Ann Fraser; Darin E Olson; Peter W F Wilson; K M Venkat Narayan; Lawrence S Phillips
Journal:  Diabetes Res Clin Pract       Date:  2010-11-26       Impact factor: 5.602

Review 6.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

7.  Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension.

Authors:  Levi Benson; Evan L Brittain; Meredith E Pugh; Eric D Austin; Kelly Fox; Lisa Wheeler; Ivan M Robbins; Anna R Hemnes
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

8.  PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.

Authors:  Ekaterina Legchenko; Philippe Chouvarine; Paul Borchert; Angeles Fernandez-Gonzalez; Erin Snay; Martin Meier; Lavinia Maegel; S Alex Mitsialis; Eva A Rog-Zielinska; Stella Kourembanas; Danny Jonigk; Georg Hansmann
Journal:  Sci Transl Med       Date:  2018-04-25       Impact factor: 17.956
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.